Ribociclib

Date 24 March 2018
Event ESMO Symposium on Signalling Pathways in Cancer 2018
Session CDK4 and CDK6 inhibitors in breast cancer
Topics Breast Cancer
Pathology/Molecular Biology
Presenter Fabrice André
Authors F. André
  • Breast Cancer Unit, Department Of Medical Oncology, Gustave Roussy Institut de Cancérologie, 94805 - Villejuif/FR